Cathie Wood’s ARK sells Absci stock, buys Prime Medicine
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
Cathie Wood's ARK ETFs made several strategic trades on November 11, 2026, significantly increasing its stake in Prime Medicine and Archer Aviation. Concurrently, ARK reduced its holdings in Absci Corp, BYD Company Limited, Honeywell Aerospace, and Teradyne, indicating a shift towards biotechnology and aerospace sectors while divesting from others.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.